IGF1 and neoplasm: Compared with either the spleen of tumor‐free mice or the spleen of EphA4‐KO tumor‐bearing mouse without IGF1 treatment, the splenic enlargement was conspicuous in the control EphA4‐WT tumor‐bearing mice (Fig. 3G).